This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Gary Carter, MMR
Associate Vice President of Market Research at Agilent Technologies, Inc


Gary Carter is currently Associate Vice President of Marketing and Strategy for Agilent’s Nucleic Acids Solutions Division which manufactures oligonucleotide API’s for clinical and commercial use. Mr. Carter has maintained a database of all clinical trials, drug approvals, investments and deals in the therapeutic oligo space for the past 18 years. This database has been used in the creation of attrition and progression rates for clinical oligo therapeutic programs and to benchmark the oligo therapeutic space against the broader biotech drug development market. Mr. Carter has a Masters degree in market research and 25 years’ experience conducting market research and strategy development projects for a wide range of companies.

Agenda Sessions

  • KEYNOTE PRESENTATION: The Oligo Therapeutic Market Landscape: Recent Approvals Lead to an Expanding Clinical Pipeline and Growth in Deal and Investment Activity

  • LIVE Keynote Q&A Including Audience Interaction: Attendees Please Bring Your Questions to This Session